(Q45832649)

16 December 2017

title

Lymphoblastoid and recombinant alpha-A interferon therapy of chronic hepatitis B virus infection. The Royal Free Hospital experience (English)

1 reference

16 December 2017

1 reference

1 reference

Thomas HC

1

1 reference

16 December 2017

Scully LJ

series ordinal

2

1 reference

16 December 2017

McDonald JA

series ordinal

3

1 reference

16 December 2017

publication date

1 January 1986

1 reference

16 December 2017

published in

Journal of Hepatology

1 reference

16 December 2017

volume

3 Suppl 2

1 reference

16 December 2017

page(s)

S193-7

1 reference

16 December 2017

Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980120-9

7 January 2021

A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980120-9

7 January 2021

Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980120-9

7 January 2021

Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980120-9

7 January 2021

Antiviral therapy in hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980120-9

7 January 2021

10.1016/S0168-8278(86)80120-9

Identifiers

DOI

1 reference

16 December 2017

PubMed ID

3298407

1 reference

16 December 2017